Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Clinical Pharmacology and Therapeutics|December 4, 2018
Oral Chaperone Therapy Migalastat for Treating Fabry Disease: Enzymatic Response and Serum Biomarker Changes After 1 YearJonas Müntze, Daniel Gensler, Octavian Maniuc, et al.
Orphanet Journal of Rare Diseases|August 17, 2018
Characterization of vertigo and hearing loss in patients with Fabry diseaseMaria Köping, Wafaa Shehata-Dieler, Dieter Schneider, et al.
Medicine|May 26, 2018
Clinical impact of the alpha-galactosidase A gene single nucleotide polymorphism -10C>T: A single-center observational studyDaniel Oder, Dan Liu, Nurcan Üçeyler, et al.
Open Heart|July 19, 2018
Association and diagnostic utility of diastolic dysfunction and myocardial fibrosis in patients with Fabry diseaseDan Liu, Daniel Oder, Tim Salinger, et al.
Cardiology Research and Practice|December 12, 2018
Association between Comorbidities and Progression of Transvalvular Pressure Gradients in Patients with Moderate and Severe Aortic Valve StenosisTim Salinger, Kai Hu, Dan Liu, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|May 26, 2018
Value of the CHA2DS2-VASc score and Fabry-specific score for predicting new-onset or recurrent stroke/TIA in Fabry disease patients without atrial fibrillationDan Liu, Kai Hu, Marie Schmidt, et al.
Circulation. Cardiovascular Genetics|October 12, 2017
α-Galactosidase A Genotype N215S Induces a Specific Cardiac Variant of Fabry DiseaseDaniel Oder, Dan Liu, Kai Hu, et al.
Journal of the American Society of Nephrology : JASN|December 17, 2016
Characterization of Classical and Nonclassical Fabry Disease: A Multicenter StudyMaarten Arends, Christoph Wanner, Derralynn Hughes, et al.
Plos One|August 2, 2017
Retrospective study of long-term outcomes of enzyme replacement therapy in Fabry disease: Analysis of prognostic factorsMaarten Arends, Marieke Biegstraaten, Derralynn A Hughes, et al.
Journal of Medical Genetics|February 14, 2018
Agalsidase alfa versus agalsidase beta for the treatment of Fabry disease: an international cohort studyMaarten Arends, Marieke Biegstraaten, Christoph Wanner, et al.
Pageof 2